Return to Main Site 617-919-3019
401 Park Drive, 7th Floor East, Boston, MA 02215

TIDO Technology Search



Invention Type

Diagnostic/Prognostic
Information Technology/Software
Medical Device
Other
Research Tool
Therapeutics

Research Area

Allergy/Respiratory/Pulmonary Disease
Anesthesia
Cardiovascular/Cardiology
Degenerative Disease
Dermatology
Endocrinology
Gastrointestinal/Nutrition
Genetic Disease
Health Care Management
Immunology
Infectious Disease
Inflammation
Internal Medicine
Metabolic Disease
Musculoskeletal
Neonatology/Pediatric
Neurology/Neuroscience
Oncology/Hematology
Ophthalmology
Otolaryngology/Audiology
Pain
Pathology
Personalized Medicine
Psychiatric Disease
Radiology
Regenerative Medicine
Reproduction/Ob-Gyn
Stem Cell
Surgery/Wound Healing
Urology
CMCC 2370

Conformation-stabilized TRAP antigens for malaria vaccines

Inventors: Timothy Springer, Adem Koksal, Chafen Lu, Gaojie Song

Invention Types: Therapeutics, Research Tool

Research Areas: Immunology, Infectious Disease

Keywords: Vaccine

For More Information Contact:  Dietz, Ryan

 

Invention Description:

The purpose of pre-erythrocytic malaria vaccines is to induce sterilizing immunity to sporozoites, the form taken by malaria-causing Plasmodium parasites before invasion of hepatocytes, maturation into merozoites and infection of red blood cells. The sporozoite stage is an attractive target for vaccine development because there is generally only one gene per protein antigen target.


Researchers at Boston Children’s Hospital have characterized the structure of one the most important targets of pre-erythrocytic vaccines, Thrombospondin Repeat Anonymous Protein (TRAP), which is known to mediate sporozoite gliding motility and cell invasion in both hosts and carriers. Using x-ray crystallography, Tim Springer and colleagues identified both open and closed conformations of TRAP. This led to the development of a method for producing and optimizing antigens that allow for the generation of antibodies to either conformation. Immunization with their modified TRAP proteins demonstrated the production of high-titer antibodies in mice and rabbit models.

Applications:

• Improved pre-erythrocytic malaria vaccines through the use of conformation-stabilized TRAP protein antigens to better evoke the generation of neutralizing antibodies.

• Research tool for various clinical and research applications including infectivity assays.

Competitive Advantages:

• Previous studies using TRAP protein antigens displayed relatively poor titers and no protection against infection.

• Expression, conformational heterogeneity, and antigenicity may be enhanced through various modifications to the engineered TRAP proteins.

• Conformation-specific TRAP antigens can be used separately or in conjunction to better stimulate an immune response.

Business Opportunity:

•Exclusive License

Key Publications: Song G, Koksal AC, Lu C, Springer TA, 2012. Shape change in the receptor for gliding motility in Plasmodium sporozoites. PNAS 109(52): 21420-21425.

Swearingen KE, Lindner SE, Shi L, et al. Interrogating the Plasmodium sporozoite surface: Indentification of surface-exposed proteins and demonstration of glycosylation on CSP and TRAP by mass spectrometry-based proteomics. PLoS Pathog. 2016 Apr 29;12(4)

IPStatus: Patented